Position in FTRE
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$3,045,000
New position
Shares Held
175,000
first reported quarter
Ownership
0.185%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#2
of 15 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARDSLEY ADVISORY PARTNERS LP holds $24,823,800 across 5 Biotechnology names. FTRE ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,000 | $7,450,950 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
30,000 | $7,229,100 | |
| 3 | ADMA |
Adma Biologics, Inc.
|
600,000 | $5,022,000 | |
| 4 | FTRE |
Fortrea Holdings Inc.
This page
|
175,000 | $3,045,000 | |
| 5 | ALDX |
Aldeyra Therapeutics, Inc.
|
975,000 | $2,076,750 |
All Filings in FTRE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,045,000 | 175,000 | Shares | Sole | 2026-07-13 | |
| No filing history on record for this holder in this stock. | ||||||